Lymphocyte-activating gene 3 expression in tumor cells predicts immune checkpoint inhibitor response in triple negative breast cancer by Ji-Yeon Kim, Ji-Yeon Kim, Jeehyun Kim, Eun Yoon Cho, Yeon Hee Park, Yeon Hee Park, Jin Seok Ahn, Jin Seok Ahn, Kyoung-Mee Kim, Kyoung-Mee Kim, Young-Hyuck Im, Young-Hyuck Im, Young-Hyuck Im

Get full text

TP53 mutations predict poor response to immunotherapy in patients with metastatic solid tumors by Ji‐Yeon Kim, Jaeyun Jung, Kyoung‐Mee Kim, Jeeyun Lee, Young‐Hyuck Im

Get full text

Improved Prediction of Survival Outcomes Using Residual Cancer Burden in Combination With Ki-67 in Breast Cancer Patients Underwent Neoadjuvant Chemotherapy by Ji-Yeon Kim, Ji-Yeon Kim, Jung Min Oh, Se Kyung Lee, Jonghan Yu, Jeong Eon Lee, Jeong Eon Lee, Seok Won Kim, Seok Jin Nam, Yeon Hee Park, Yeon Hee Park, Yeon Hee Park, Jin Seok Ahn, Kyunga Kim, Kyunga Kim, Kyunga Kim, Young-Hyuck Im, Young-Hyuck Im, Young-Hyuck Im

Get full text

Local Laboratory Testing of Germline BRCA Mutations vs. Myriad: A Single-Institution Experience in Korea by Joohyun Hong, Jiyun Lee, Minsuk Kwon, Ji-Yeon Kim, Jong-Won Kim, Jin Seok Ahn, Young-Hyuck Im, Yeon Hee Park

Get full text

The Tumor–Fat Interface Volume of Breast Cancer on Pretreatment MRI Is Associated with a Pathologic Response to Neoadjuvant Chemotherapy by Hwan-ho Cho, Minsu Park, Hyunjin Park, Eun Sook Ko, Na Young Hwang, Young-Hyuck Im, Kyounglan Ko, Sung Hoon Sim

Get full text

Impact of high dose radiotherapy for breast tumor in locoregionally uncontrolled stage IV breast cancer: a need for a risk-stratified approach by Nalee Kim, Haeyoung Kim, Won Park, Won Kyung Cho, Tae Gyu Kim, Young-Hyuck Im, Jin Seok Ahn, Yeon Hee Park, Ji-Yeon Kim

Get full text

Prognostic value of structural variants in early breast cancer patients by Ji-Yeon Kim, Kyunghee Park, Woong-Yang Park, Jin Seok Ahn, Young-Hyuck Im, Jeong Eon Lee, Seok Won Kim, Seok Jin Nam, Jonghan Yu, Yeon Hee Park

Get full text

PALOMA-3: Phase III Trial of Fulvestrant With or Without Palbociclib in Premenopausal and Postmenopausal Women With Hormone Receptor–Positive, Human Epidermal Growth Factor Recepto... by Hiroji Iwata, Seock-Ah Im, Norikazu Masuda, Young-Hyuck Im, Kenichi Inoue, Yoshiaki Rai, Rikiya Nakamura, Jee Hyun Kim, Justin T. Hoffman, Ke Zhang, Carla Giorgetti, Shrividya Iyer, Patrick T. Schnell, Cynthia Huang Bartlett, Jungsil Ro

Get full text

Breast cancers with neuroendocrine differentiation: Retrospective case studies series from a single institution based on the 2019 WHO classification by Youngkyung Jeon, Ji-Yeon Kim, Jin Seok Ahn, Young-Hyuck Im, Kyuehee Choi, Sun Young Jeong, Yeji Jung, Jaeyeon Jang, Dae-Ho Choi, Joohyun Hong, Hyo Jung Kim, Soo Youn Cho, Yeon Hee Park

Get full text

ER+, HER2− advanced breast cancer treated with taselisib and fulvestrant: genomic landscape and associated clinical outcomes by Jessica W. Chen, William Jacot, Javier Cortés, Ian E. Krop, Susan Dent, Nadia Harbeck, Michelino De Laurentiis, Véronique Diéras, Young‐Hyuck Im, Thomas J. Stout, Frauke Schimmoller, Heidi M. Savage, Katherine E. Hutchinson, Timothy R. Wilson

Get full text

Genomic characteristics of triple negative apocrine carcinoma: a comparison to triple negative breast cancer by Ji-Yeon Kim, Sabin Park, Eun Yoon Cho, Jeong Eon Lee, Hae Hyun Jung, Byung Joo Chae, Seok Won Kim, Seok Jin Nam, Soo Youn Cho, Yeon Hee Park, Jin Seok Ahn, Semin Lee, Young-Hyuck Im

Get full text

Benefit of postoperative regional nodal irradiation in patients receiving preoperative systemic therapy with docetaxel/carboplatin/trastuzumab/pertuzumab for HER2-positive breast c... by Nalee Kim, Ji-Yeon Kim, Won Park, Won Kyung Cho, Tae Gyu Kim, Young-Hyuck Im, Jin Seok Ahn, Jeong Eon Lee, Seok Jin Nam, Seok Won Kim, Jonghan Yu, Byung Joo Chae, Sei Kyung Lee, Jai-Min Ryu, Yeon Hee Park, Haeyoung Kim

Get full text